UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 182

Sortiert nach

A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal

PLoS computational biology, 2018-02, Vol.14 (2), p.e1005965-e1005965

2018

Link zum Volltext

Verfügbarkeit prüfen

Mobile applications in oncology: is it possible for patients and healthcare professionals to easily identify relevant tools?

Annals of medicine (Helsinki), 2016-10, Vol.48 (7), p.509-515

2016

Link zum Volltext

Verfügbarkeit prüfen

Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2167-2172

2013

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers of response to immunotherapy in early stage non-small cell lung cancer

European journal of cancer (1990), 2023-05, Vol.184, p.179-196

2023

Link zum Volltext

Verfügbarkeit prüfen

Thérapies moléculaires ciblées et cytotoxiques : frères ennemis ou alliés de poids ?

Bulletin du cancer, 2015-06, Vol.102 (6), p.S91-S92

2015

Link zum Volltext

Verfügbarkeit prüfen

Should Adjuvant Radiation Therapy Be Systematically Proposed for Male Breast Cancer? A Systematic Review

Anticancer research, 2018-01, Vol.38 (1), p.23-31

2018

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy for stage I lung cancer in the elderly

Bulletin du cancer, 2015-05, Vol.102 (5), p.401

Vignot, Stéphane

2015

Link zum Volltext

Verfügbarkeit prüfen

A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network)

Critical reviews in oncology/hematology, 2014-08, Vol.91 (2), p.142-158

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular analysis for refractory rare cancers: Sequencing battle continues – learnings for the MOSCATO-01 study

Critical reviews in oncology/hematology, 2023-01, Vol.181, p.103888-103888, Article 103888

2023

Link zum Volltext

Verfügbarkeit prüfen

Nouvelles modalités de prescription des autorisations temporaires d’utilisation nominatives (ATUn) : une étape clé dans l’accès à l’innovation

Bulletin du cancer, 2019-11, Vol.106 (11), p.943-945

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: Evaluation of concordance between genomic and transcriptional profiles

European journal of cancer (1990), 2015-05, Vol.51 (7), p.791-799

2015

Link zum Volltext

Verfügbarkeit prüfen

Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority

Frontiers in pharmacology, 2022-08, Vol.13, p.972660-972660

2022

Link zum Volltext

Verfügbarkeit prüfen

Obesity and cancer

Bulletin du cancer, 2017-01, Vol.104 (1), p.30

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologie des Cancers : un salutaire retour aux sources

Bulletin du cancer, 2015-09, Vol.102 (9), p.799-799

Vignot, Stéphane

2015

Link zum Volltext

Verfügbarkeit prüfen

Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

Frontiers in pharmacology, 2021-04, Vol.12, p.635841-635841

2021

Link zum Volltext

Verfügbarkeit prüfen

Brillants, précis, stimulants, convaincants, polémiques

Bulletin du cancer, 2015-06, Vol.102 (6), p.S1-S1

2015

Link zum Volltext

Verfügbarkeit prüfen

High-dose chemotherapy for tumor treatment: The beginning of the end?

Bulletin du cancer, 2017-04, Vol.104 (4), p.299

2017

Link zum Volltext

Verfügbarkeit prüfen

Abiratérone : bénéfice en survie globale et questions subsidiaires

Bulletin du cancer, 2015-06, Vol.102 (6), p.487-488

Vignot, Stéphane

2015

Link zum Volltext

Verfügbarkeit prüfen

Chimiothérapie adjuvante des cancers bronchiques de stade I chez les sujets âgés. Quand une étude qui se veut positive peut s’avérer contre-productive

Bulletin du cancer, 2015-05, Vol.102 (5), p.401-402

Vignot, Stéphane

2015

Link zum Volltext

Verfügbarkeit prüfen

Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort

British journal of cancer, 2019-12, Vol.121 (12), p.1001-1008

2019

Link zum Volltext

Verfügbarkeit prüfen

Discrepancies between primary tumor and metastasis: A literature review on clinically established biomarkers

Critical reviews in oncology/hematology, 2012-12, Vol.84 (3), p.301-313

2012

Link zum Volltext

Verfügbarkeit prüfen

Actualités, quand tu nous tiens

Bulletin du cancer, 2024-02, Vol.111 (2), p.127-128

2024

Link zum Volltext

Verfügbarkeit prüfen

De 2023 à 2024 : consolider nos acquis, garder le cap de l’innovation et du progrès

Bulletin du cancer, 2024-01, Vol.111 (1), p.1-2

2024

Link zum Volltext

Verfügbarkeit prüfen

FGF/FGFR blockade: New insights in endometrial cancer

Bulletin du cancer, 2015-12, Vol.102 (12), p.964

2015

Link zum Volltext

Verfügbarkeit prüfen

Integrating genomics in head and neck cancer treatment: Promises and pitfalls

Critical reviews in oncology/hematology, 2015-09, Vol.95 (3), p.397-406

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(181)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(75)
Science & Technology
(75)
Humans
(72)
Oncology
(71)
France
(18)
Female
(16)
Life Sciences
(16)
Hematology
(14)
Sciences Biologiques Et Medicales
(14)
Sciences Medicales
(14)
Tumeurs
(14)
Antineoplastic Agents - Therapeutic Use
(13)
Periodicals As Topic
(13)
Male
(12)
Cancer
(11)
Neoplasms - Therapy
(11)
Prognosis
(10)
Lung Neoplasms - Drug Therapy
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)
Human Health And Pathology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal

Mobile applications in oncology: is it possible for patients and healthcare professionals to easily identify relevant tools?

Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non–Small-Cell Lung Cancer

Biomarkers of response to immunotherapy in early stage non-small cell lung cancer

Thérapies moléculaires ciblées et cytotoxiques : frères ennemis ou alliés de poids ?

Should Adjuvant Radiation Therapy Be Systematically Proposed for Male Breast Cancer? A Systematic Review

Adjuvant chemotherapy for stage I lung cancer in the elderly

A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network)

Molecular analysis for refractory rare cancers: Sequencing battle continues – learnings for the MOSCATO-01 study

Nouvelles modalités de prescription des autorisations temporaires d’utilisation nominatives (ATUn) : une étape clé dans l’accès à l’innovation

Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: Evaluation of concordance between genomic and transcriptional profiles

Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority

Obesity and cancer

Pharmacologie des Cancers : un salutaire retour aux sources

Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

Brillants, précis, stimulants, convaincants, polémiques

High-dose chemotherapy for tumor treatment: The beginning of the end?

Abiratérone : bénéfice en survie globale et questions subsidiaires

Chimiothérapie adjuvante des cancers bronchiques de stade I chez les sujets âgés. Quand une étude qui se veut positive peut s’avérer contre-productive

Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort

Discrepancies between primary tumor and metastasis: A literature review on clinically established biomarkers

Actualités, quand tu nous tiens

De 2023 à 2024 : consolider nos acquis, garder le cap de l’innovation et du progrès

FGF/FGFR blockade: New insights in endometrial cancer

Integrating genomics in head and neck cancer treatment: Promises and pitfalls

Suchergebnisse filtern